Sidoti Csr Analysts Reduce Earnings Estimates for USNA

Key Points

• Sidoti Csr has lowered its Q3 2025 earnings estimate for USANA Health Sciences to $0.47 per share, down from a previous estimate of $0.65.
• USANA Health Sciences reported Q2 earnings of $0.74 per share, surpassing consensus estimates of $0.54, with revenues of $235.85 million.
• Shares of USANA Health Sciences have recently seen increased institutional interest, with several hedge funds raising their stakes over the past quarters.

USANA Health Sciences, Inc. (NYSE:USNA - Free Report) - Equities research analysts at Sidoti Csr cut their Q3 2025 earnings per share (EPS) estimates for USANA Health Sciences in a report released on Wednesday, July 23rd. Sidoti Csr analyst A. Lebiedzinski now forecasts that the company will post earnings of $0.47 per share for the quarter, down from their prior forecast of $0.65. The consensus estimate for USANA Health Sciences' current full-year earnings is $2.45 per share.

USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.54 by $0.20. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. The company had revenue of $235.85 million for the quarter, compared to the consensus estimate of $225.20 million.

Separately, Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

USANA Health Sciences Price Performance

NYSE:USNA traded up $0.08 during trading hours on Friday, reaching $32.03. 30,021 shares of the company were exchanged, compared to its average volume of 184,796. The company has a market capitalization of $596.40 million, a P/E ratio of 17.79, a P/E/G ratio of 1.02 and a beta of 0.64. USANA Health Sciences has a 1-year low of $23.10 and a 1-year high of $45.86. The business has a 50 day moving average of $30.89 and a 200 day moving average of $30.02.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, CFO G Doug Iiekking sold 4,548 shares of the firm's stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Walter Noot sold 6,291 shares of USANA Health Sciences stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 12,013 shares of company stock valued at $360,149. 0.63% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On USANA Health Sciences

Hedge funds have recently modified their holdings of the company. PNC Financial Services Group Inc. lifted its position in shares of USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock worth $27,000 after buying an additional 771 shares in the last quarter. Versant Capital Management Inc raised its holdings in shares of USANA Health Sciences by 542.5% in the 1st quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after purchasing an additional 971 shares during the period. Parallel Advisors LLC raised its holdings in shares of USANA Health Sciences by 8,141.2% in the 1st quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock worth $38,000 after purchasing an additional 1,384 shares during the period. KLP Kapitalforvaltning AS bought a new stake in USANA Health Sciences during the 4th quarter valued at $83,000. Finally, CWM LLC raised its holdings in USANA Health Sciences by 109.7% during the 2nd quarter. CWM LLC now owns 2,762 shares of the company's stock valued at $84,000 after acquiring an additional 1,445 shares during the period. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.